Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jun 28, 2009; 15(24): 2995-3002
Published online Jun 28, 2009. doi: 10.3748/wjg.15.2995
Published online Jun 28, 2009. doi: 10.3748/wjg.15.2995
Groups | Tumor mass (g, mean ± SD) | Mass inhibitory rate (%) | Tumor volume (cm3, mean ± SD) | Volume inhibitory rate (%) |
Control | 0.6145 ± 0.2296 | 0.00 | 0.7195 ± 0.3231 | 0.00 |
As2O3 | 0.5885 ± 0.1628 | 5.86 | 0.6015 ± 0.2282 | 16.40 |
Fe2O3 | 0.5365 ± 0.2792 | 12.69 | 0.5997 ± 0.2518 | 16.65 |
As2O3/Fe2O3 | 0.4548 ± 0.2591 | 26.04 | 0.6252 ± 0.4034 | 21.45 |
Fe2O3 with MFH | 0.1921 ± 0.0395 | 68.74b | 0.2373 ± 0.0874 | 67.02b |
As2O3/Fe2O3 with MFH | 0.1057 ± 0.0510 | 82.79bc | 0.1183 ± 0.0726 | 83.56bc |
- Citation: Wang ZY, Song J, Zhang DS. Nanosized As2O3/Fe2O3 complexes combined with magnetic fluid hyperthermia selectively target liver cancer cells. World J Gastroenterol 2009; 15(24): 2995-3002
- URL: https://www.wjgnet.com/1007-9327/full/v15/i24/2995.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.2995